# The Conduit EIS Impact Fund

> The Conduit EIS Impact Fund is a VC fund in London backing Health Care and Manufacturing. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 9
- Last investment: May 2026
- Lead investor: 33%
- Last updated: Aug 2026
- Website: https://www.theconduitconnect.com/fund

The Conduit EIS Impact Fund is a VC fund in London focused on Health Care and Manufacturing. The Conduit EIS Impact Fund provides an opportunity to invest in a diverse portfolio of early and growth stage businesses.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 33% |
| Manufacturing | 3 | 33% |
| Mineral | 1 | 11% |
| Software | 1 | 11% |
| Wellness | 1 | 11% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 44% |
| Pre-Seed | 3 | 33% |
| Series A | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Zonova | Zonova has developed an antimicrobial additive technology that integrates directly into the polymers used in medical device manufacture, designed to help prevent healthcare-associated infections, a problem affecting roughly 1 in 10 hospital patients worldwide (WHO, 2011). Our patented Z-ROS® chemistry is a non-leaching antimicrobial additive basedon reactive-oxygen-species generation at the polymer surface. It does not use actives, antibiotics or biocides.Z-ROS® is in development for high infection-risk device categories including vascular access devices, orthopaedic implants, urology (connectors, valves, catheters), endotracheal tubes, and pelvic health devices. The intended commercial model is licensing to medical device manufacturers, with masterbatch supply through a contracted compounder. | $2.8M | Seed | May 26, 2026 |  |
| Forge Minerals | Forge Minerals is at the cutting edge of CO2 mineralization and carbon-negative mineral production. | $1.4M | Pre-Seed | Jan 27, 2026 |  |
| HotGreen Solutions | HotGreen is an industrial high-temperature heat pump company providing process heat from electricity. | $1.6M | Pre-Seed | Oct 14, 2025 |  |
| Gladys | Gladys is a revolutionary social care software platform set to transform the caregiving landscape through innovation, empowerment, and direct connections. With a commitment to cutting out intermediaries, Gladys brings local carers, helpers, and families together in a seamless digital ecosystem. Led by a seasoned co-founding team with extensiveexperience in the sector, Gladys is uniquely positioned to address the challenges faced by the social care industry. As a female-led tech business based in the UK, Gladys is dedicated to driving change, simplifying processes, and enhancing the quality of care provided to vulnerable individuals. Backed by venture capital firm Antler, Gladys is poised to redefine social care, empowering caregivers and families. | $2M | Seed | Oct 13, 2025 |  |
| Perci Health | Perci Health provides telehealth services to people living with cancer. Our mission is to change perceptions about life after treatment. | $4.1M | Seed | Jun 11, 2025 |  |
| ReBorn® Homewares | ReBorn purpose is to transform the sustainability of the global homewares industry. We are committed to creating the most stylish and planet-friendly homewares, and driving collective change in the UK and beyond .Our five key principles are: 1.Recycling Waste 2.Local production 3.Circular Design 4.Stylish Solutions 5.Collaborative Power |  | Pre-Seed | Nov 01, 2022 |  |
| Thalamos | Thalamos is pioneering long overdue change in this sector. On our platform, psychiatrists can complete, store and share clinical forms. They can handle all their finances and invoicing. They can also securely manage their diaries. Information on the platform is fully encrypted and auditable, meaning psychiatrists can reduce risk and improveprocesses, giving them more time to spend on delivering care. | $1M | Seed | Sep 01, 2022 |  |
| MiAlgae | MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market. | $2.8M | Series A | Aug 17, 2022 |  |
| MiAlgae | MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market. | $2.8M | Series A | Aug 17, 2022 |  |

9 of 9 investments shown.

## Co-investors
- [Old College Capital](https://shizune.co/investors/profile/old-college-capital) — VC Fund, 3 deals together
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 3 deals together
- [Equity Gap](https://shizune.co/investors/profile/equity-gap) — VC Fund, 2 deals together
- [SIS Ventures](https://shizune.co/investors/profile/sis-ventures) — VC Fund, 2 deals together
- [Almanac Ventures](https://shizune.co/investors/profile/almanac-ventures) — VC Fund, 1 deal together
- [Angel Academe](https://shizune.co/investors/profile/angel-academe) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does The Conduit EIS Impact Fund invest in?

The Conduit EIS Impact Fund invests primarily in Health Care, Manufacturing and Mineral startups, most often at Seed and Pre-Seed stage. Most of the 9 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did The Conduit EIS Impact Fund last invest?

The most recent investment recorded for The Conduit EIS Impact Fund closed in May 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co